Genome & Company (KOSDAQ: 314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,915.00
-15.00 (-0.51%)
Nov 15, 2024, 9:00 AM KST

Genome & Company Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Revenue
23,92514,29614,085451.25150.5845.83
Other Revenue
0--0---
Revenue
23,92514,29614,085451.25150.5845.83
Revenue Growth (YoY)
59.64%1.50%3021.27%199.67%228.54%-
Cost of Revenue
11,72210,2328,48777.01-16.87
Gross Profit
12,2034,0645,598374.24150.5828.96
Selling, General & Admin
29,20628,67719,66414,12312,9155,933
Research & Development
19,96925,66636,79321,26313,6697,773
Other Operating Expenses
-----21.6
Operating Expenses
53,99259,15663,11036,46126,77913,850
Operating Income
-41,790-55,092-57,512-36,087-26,629-13,821
Interest Expense
-2,793-1,738-175-54.92-1,236-2,112
Interest & Investment Income
4,2374,121850.8458.17112.52113.72
Earnings From Equity Investments
-2,325-2,325----
Currency Exchange Gain (Loss)
-21.72-40.56-29.46-468.0276.85-29.22
Other Non Operating Income (Expenses)
555.173,252-1,112161.16-3,418-68,819
EBT Excluding Unusual Items
-42,137-51,824-57,979-35,991-31,093-84,669
Gain (Loss) on Sale of Investments
62.7446.44-54.79---
Gain (Loss) on Sale of Assets
-145.21-77.110.69-12.93-92.58-
Pretax Income
-42,220-51,855-58,033-36,004-31,186-84,669
Income Tax Expense
-1,696-1,202-1,083---
Earnings From Continuing Operations
-40,524-50,653-56,950-36,004-31,186-84,669
Minority Interest in Earnings
2,6393,1875,1121,887453.56-
Net Income
-37,885-47,466-51,838-34,117-30,732-84,669
Net Income to Common
-37,885-47,466-51,838-34,117-30,732-84,669
Shares Outstanding (Basic)
292828271916
Shares Outstanding (Diluted)
292828271916
Shares Change (YoY)
3.64%0.32%4.71%39.60%20.11%-
EPS (Basic)
-1297.31-1680.81-1841.50-1269.10-1595.95-5281.23
EPS (Diluted)
-1297.31-1681.00-1841.50-1269.10-1596.00-5281.23
Free Cash Flow
-36,387-51,077-50,399-29,034-19,662-10,736
Free Cash Flow Per Share
-1246.01-1808.70-1790.39-1080.03-1021.03-669.65
Gross Margin
51.00%28.43%39.74%82.93%100.00%63.19%
Operating Margin
-174.67%-385.37%-408.34%-7997.20%-17683.84%-30155.63%
Profit Margin
-158.35%-332.02%-368.05%-7560.62%-20409.23%-184731.34%
Free Cash Flow Margin
-152.09%-357.28%-357.83%-6434.20%-13057.09%-23423.41%
EBITDA
-33,806-46,820-48,051-33,496-25,164-13,251
D&A For EBITDA
7,9848,2729,4622,5911,464570.03
EBIT
-41,790-55,092-57,512-36,087-26,629-13,821
Advertising Expenses
-2,0331,505987.32207.9933.84
Source: S&P Capital IQ. Standard template. Financial Sources.